Expression of neuronal CXCL10 induced by rabies virus infection initiates infiltration of inflammatory cells, production of chemokines and cytokines, and enhancement of blood-brain barrier permeability

Journal of Virology

Volumn 89, Issue 1, 2015, Pages 870-876

  Chai, Qingqing ^a,b   She, Ruiping ^b,c   Huang, Ying ^b   Fu, Zhen F ^a,b  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

^b UNIVERSITY OF GEORGIA   (United States)

^c CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN PROTEIN; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; CXCL10 PROTEIN, MOUSE; TIGHT JUNCTION PROTEIN;

ANIMAL TISSUE; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; INFLAMMATORY CELL; INTERFERON PRODUCTION; LYMPHOCYTIC INFILTRATION; MEMBRANE PERMEABILITY; MICROGLIA; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RABIES; RABIES VIRUS; TH17 CELL; TIGHT JUNCTION; VIRUS NEUTRALIZATION; ANIMAL; BIOSYNTHESIS; FEMALE; GENE EXPRESSION PROFILING; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; LEUKOCYTE; NERVE CELL; PATHOPHYSIOLOGY; PERMEABILITY; PHYSIOLOGY; SECRETION (PROCESS); TIME; VIROLOGY;

MUS; RABIES VIRUS;

ANIMALS; BLOOD-BRAIN BARRIER; CHEMOKINE CXCL10; CYTOKINES; FEMALE; GENE EXPRESSION PROFILING; LEUKOCYTES; MICE, INBRED ICR; NEURONS; PERMEABILITY; RABIES; RABIES VIRUS; TIGHT JUNCTION PROTEINS; TIME FACTORS;

EID: 84919459586     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02154-14     Document Type: Article

References (31)

1. Fu ZF. 1997. Rabies and rabies research: past, present and future. Vaccine 15(Suppl):S20-S24. http://dx.doi.org/10.1016/S0264-410X(96)00312-X.
2. World Health Organization. 2013.WHOExpert Consultation on Rabies. Second report. World Health Organization technical report series 982. WHO, Geneva, Switzerland. http://apps.who.int/iris/bitstream/10665/85346/1/9789240690943_eng.pdf.
3. Wang ZW, Sarmento L, Wang Y, Li XQ, Dhingra V, Tseggai T, Jiang B, Fu ZF. 2005. Attenuated rabies virus activates, while pathogenic rabies virus evades, the host innate immune responses in the central nervous system. J Virol 79:12554-12565. http://dx.doi.org/10.1128/JVI.79.19.12554-12565.2005.
4. Roy A, Phares TW, Koprowski H, Hooper DC. 2007. Failure to open the blood-brain barrier and deliver immune effectors to central nervous system tissues leads to the lethal outcome of silver-haired bat rabies virus infection. J Virol 81:1110-1118. http://dx.doi.org/10.1128/JVI.01964-06.
5. Hooper DC, Phares TW, Fabis MJ, Roy A. 2009. The production of antibody by invading B cells is required for the clearance of rabies virus from the central nervous system. PLoS Negl Trop Dis 3:e535. http://dx.doi.org/10.1371/journal.pntd.0000535.
6. Klein RS, Izikson L, Means T, Gibson HD, Lin E, Sobel RA, Weiner HL, Luster AD. 2004. IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis. J Immunol 172:550-559. http://dx.doi.org/10.4049/jimmunol.172.1.550.
7. Dufour JH, Dziejman M, Liu MT, Leung JH, Lane TE, Luster AD. 2002. IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol 168:3195-3204. http://dx.doi.org/10.4049/jimmunol.168.7.3195.
8. Chai Q, He WQ, Zhou M, Lu H, Fu ZF. 2014. Enhancement of bloodbrain barrier permeability and reduction of tight junction protein expression are modulated by chemokines/cytokines induced by rabies virus infection. J Virol 88:4698-4710. http://dx.doi.org/10.1128/JVI.03149-13.
9. Nagpal ML, Davis J, Lin T. 2006. Overexpression of CXCL10 in human prostate LNCaP cells activates its receptor (CXCR3) expression and inhibits cell proliferation. Biochim Biophys Acta 1762:811-818. http://dx.doi.org/10.1016/j.bbadis.2006.06.017.
10. Nakajima C, Mukai T, Yamaguchi N, Morimoto Y, Park WR, Iwasaki M, Gao P, Ono S, Fujiwara H, Hamaoka T. 2002. Induction of the chemokine receptor CXCR3 on TCR-stimulated T cells: dependence on the release from persistent TCR-triggering and requirement for IFNgamma stimulation. Eur J Immunol 32:1792-1801. http://dx.doi.org/10.1002/1521-4141(200206)32:6<1792::AID-IMMU1792>3.0.CO;2-0.
11. Klein RS, Lin E, Zhang B, Luster AD, Tollett J, Samuel MA, Engle M, Diamond MS. 2005. Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis. J Virol 79:11457-11466. http://dx.doi.org/10.1128/JVI.79.17.11457-11466.2005.
12. Luster AD, Ravetch JV. 1987. Biochemical characterization of a gamma interferon-inducible cytokine (IP-10). J Exp Med 166:1084-1097. http://dx.doi.org/10.1084/jem.166.4.1084.
13. Harikumar KB, Yester JW, Surace MJ, Oyeniran C, Price MM, Huang WC, Hait NC, Allegood JC, Yamada A, Kong X, Lazear HM, Bhardwaj R, Takabe K, Diamond MS, Luo C, Milstien S, Spiegel S, Kordula T. 2014. K63-linked polyubiquitination of transcription factor IRF1 is essential for IL-1-induced production of chemokines CXCL10 and CCL5. Nat Immunol 15:231-238. http://dx.doi.org/10.1038/ni.2810.
14. Singh UP, Singh S, Singh R, Cong Y, Taub DD, Lillard JW, Jr. 2008. CXCL10-producing mucosal CD4+ T cells, NK cells, and NKT cells are associated with chronic colitis in IL-10(-/-) mice, which can be abrogated by anti-CXCL10 antibody inhibition. J Interferon Cytokine Res 28:31-43. http://dx.doi.org/10.1089/jir.2007.0059.
15. Nakamichi K, Inoue S, Takasaki T, Morimoto K, Kurane I. 2004. Rabies virus stimulates nitric oxide production and CXC chemokine ligand 10 expression in macrophages through activation of extracellular signalregulated kinases 1 and 2. J Virol 78:9376-9388. http://dx.doi.org/10.1128/JVI.78.17.9376-9388.2004.
16. Asensio VC, Campbell IL. 1997. Chemokine gene expression in the brains of mice with lymphocytic choriomeningitis. J Virol 71:7832-7840.
17. Asensio VC, Maier J, Milner R, Boztug K, Kincaid C, Moulard M, Phillipson C, Lindsley K, Krucker T, Fox HS, Campbell IL. 2001. Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10/IP-10 gene expression by astrocytes in vivo and in vitro. J Virol 75:7067-7077. http://dx.doi.org/10.1128/JVI.75.15.7067-7077.2001.
18. Lane TE, Asensio VC, Yu N, Paoletti AD, Campbell IL, Buchmeier MJ. 1998. Dynamic regulation of alpha-and beta-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease. J Immunol 160:970-978.
19. Liu MT, Keirstead HS, Lane TE. 2001. Neutralization of the chemokine CXCL10 reduces inflammatory cell invasion and demyelination and improves neurological function in a viral model of multiple sclerosis. J Immunol 167:4091-4097. http://dx.doi.org/10.4049/jimmunol.167.7.4091.
20. Fife BT, Kennedy KJ, Paniagua MC, Lukacs NW, Kunkel SL, Luster AD, Karpus WJ. 2001. CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis. J Immunol 166:7617-7624. http://dx.doi.org/10.4049/jimmunol.166.12.7617.
21. Wildbaum G, Netzer N, Karin N. 2002. Plasmid DNA encoding IFNgamma-inducible protein 10 redirects antigen-specific T cell polarization and suppresses experimental autoimmune encephalomyelitis. J Immunol 168:5885-5892. http://dx.doi.org/10.4049/jimmunol.168.11.5885.
22. Narumi S, Kaburaki T, Yoneyama H, Iwamura H, Kobayashi Y, Matsushima K. 2002. Neutralization of IFN-inducible protein 10/CXCL10 exacerbates experimental autoimmune encephalomyelitis. Eur J Immunol 32:1784-1791. http://dx.doi.org/10.1002/1521-4141(200206)32:6<1784::AID-IMMU1784>3.0.CO;2-R.
23. He X, Ren J, Xu F, Ferguson MR, Li G. 2009. Localization of West Nile virus in monkey brain: double staining antigens immunohistochemically of neurons, neuroglia cells and West Nile Virus. Int J Clin Exp Pathol 3:156-161.
24. Chua TC, Yao P, Akther J, Morris DL. 2010. Impact of tumor angiogenesis in peritoneal mesothelioma after radical cytoreduction and hyperthermic intraperitoneal chemotherapy. Pathol Oncol Res 16:217-222. http://dx.doi.org/10.1007/s12253-009-9210-9.
25. Phares TW, Fabis MJ, Brimer CM, Kean RB, Hooper DC. 2007. A peroxynitrite-dependent pathway is responsible for blood-brain barrier permeability changes during a central nervous system inflammatory response: TNF-alpha is neither necessary nor sufficient. J Immunol 178: 7334-7343. http://dx.doi.org/10.4049/jimmunol.178.11.7334.
26. Shechter R, London A, Schwartz M. 2013. Orchestrated leukocyte recruitment to immune-privileged sites: absolute barriers versus educational gates. Nat Rev Immunol 13:206-218. http://dx.doi.org/10.1038/nri3391.
27. Huppert J, Closhen D, Croxford A, White R, Kulig P, Pietrowski E, Bechmann I, Becher B, Luhmann HJ, Waisman A, Kuhlmann CR. 2010. Cellular mechanisms of IL-17-induced blood-brain barrier disruption. FASEB J 24:1023-1034. http://dx.doi.org/10.1096/fj.09-141978.
28. Tzartos JS, Friese MA, Craner MJ, Palace J, Newcombe J, Esiri MM, Fugger L. 2008. Interleukin-17 production in central nervous systeminfiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am J Pathol 172:146-155. http://dx.doi.org/10.2353/ajpath.2008.070690.
29. Muller M, Carter S, Hofer MJ, Campbell IL. 2010. The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity-a tale of conflict and conundrum. Neuropathol Appl Neurobiol 36:368-387. http://dx.doi.org/10.1111/j.1365-2990.2010.01089.x.
30. Whiting D, Hsieh G, Yun JJ, Banerji A, Yao W, Fishbein MC, Belperio J, Strieter RM, Bonavida B, Ardehali A. 2004. Chemokine monokine induced by IFN-gamma/CXC chemokine ligand 9 stimulates T lymphocyte proliferation and effector cytokine production. J Immunol 172:7417-7424. http://dx.doi.org/10.4049/jimmunol.172.12.7417.
31. Kuang Y, Lackay SN, Zhao L, Fu ZF. 2009. Role of chemokines in the enhancement of BBB permeability and inflammatory infiltration after rabies virus infection. Virus Res 144:18-26. http://dx.doi.org/10.1016/j.virusres.2009.03.014.